يستعمل دواء تيجاجلور 400مجم 28 اقراصtigaglor 400mg 28 tablets anti-viral anti-viral

indications and usage: -it is a hepatitis c virus (hcv) nucleotide analog ns5b polymerase inhibitor indicated for the treatment of chronic hepatitis c (chc) infection as a component of a combination antiviral treatment regimen. -*efficacy has been established in subjects with hcv genotype 1 2 3 or 4 infection including those with hepatocellular carcinoma meeting milan criteria (awaiting liver transplantation) and those with hcv/hiv-1 co-infection. - -*dosage and administration: -* one 400 mg tablet taken once daily with or without food. -* should be used in combination with ribavirin or in combination with pegylated interferon and ribavirin for the treatment of chc. -recommended combination therapy: -hcv mono-infected and hcv/hiv-1 co-infected - treatment duration -genotype 1 or 4 sovaldi + peg-interferon alfa + ribavirin 12 weeks -genotype 2 so